Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

House, Senate Health-Care Legislation: Side-by-Side Comparison
Bloomberg
Monday, November 9, 2009 - 10:02am
tags:
healthcare reform, healthcare bill
Alcon Boosts Presence In Eye Disease Market
Yahoo/Investors Business Daily
Monday, November 9, 2009 - 10:00am
tags:
eye disease, Alcon
Boston Scientific Sets $296 Million Settlement on Devices
WSJ Online
Monday, November 9, 2009 - 9:59am
tags:
medical devices, Boston Scientific, settlements
No Product Revenues, Plenty of Risk: Buy Exelixis?
CNBC
Monday, November 9, 2009 - 9:58am
tags:
Exelixis, GSK, Bristol-Myers Squibb, Sanofi, Roche, Genentech
China Is Growth Market for Novartis
Seeking Alpha
Sunday, November 8, 2009 - 12:57pm
tags:
Novartis, China
Chinese co to fund D-Pharm Phase III trial
Globes, Israel
Sunday, November 8, 2009 - 12:55pm
tags:
D-pharm, Wanbang Biopharmaceuticals
Small Cap Biotechs and Government Policy Makers Meet in D.C.(OTC:ADXS),(AMEX:CVM),(CVE:IMV)
Smallcap Network
Sunday, November 8, 2009 - 12:54pm
tags:
biotech
Dr. Reddy’s Laboratories (RDY): Best Pharma Stock In India
The Wall St Transcript
Sunday, November 8, 2009 - 12:48pm
tags:
Dr Reddy's
Why We Need A Healthy Biotech Industry
Worcester Business Journal
Sunday, November 8, 2009 - 12:47pm
tags:
biotech
Novexel Starts Phase II Clinical Trial With NXL103 In Adults With Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
prnewschannel.com
Sunday, November 8, 2009 - 12:38pm
tags:
Novexel, skin infection
Biotech Blooms at Eli Lilly
Seeking Alpha
Sunday, November 8, 2009 - 12:37pm
tags:
biotech, Eli Lilly
Santarus Inc. Q3 2009 Earnings Call Transcript
Seeking Alpha
Sunday, November 8, 2009 - 12:35pm
tags:
Santarus
Living Without Blockbusters
Forbes
Sunday, November 8, 2009 - 12:31pm
tags:
Sanofi
Money-Making Mood Stabilizers
CNBC
Sunday, November 8, 2009 - 12:29pm
tags:
Targacept
Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme
BusinessWire
Sunday, November 8, 2009 - 12:28pm
tags:
Halozyme, insulin, Lispro
Cramer’s 8 Picks for Cancer's Cure
CNBC
Sunday, November 8, 2009 - 12:26pm
tags:
cancer
Genmab to cut 130 jobs in Brooklyn Park, sell biotech factory
bizjournals.com
Sunday, November 8, 2009 - 12:24pm
tags:
Genmab
DX-88 (ecallantide) Demonstrated Relief of Symptoms in Hereditary Angioedema Acute Attacks in All Attack Locations
BusinessWire
Sunday, November 8, 2009 - 12:23pm
tags:
escallantide, Dyax
Micromet takes back MedImmune's blinatumomab rights
Fierce Biotech
Friday, November 6, 2009 - 10:46am
tags:
MedImmune, blinatumomab, Micromet
Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Yahoo/AP
Friday, November 6, 2009 - 10:45am
tags:
Xyrem, earnings, Jazz Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.